New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Teva Pharmaceutical Industries Limited
TEVA
Shape
US Flag

NYSE

19B

Drug Manufacturers - Specialty & Generic

Next Earning date - 29 Jan 2025

19B

Drug Manufacturers - Specialty & Generic

Next Earning date - 29 Jan 2025

17.11USD
Shape-0.26 ( -1.50%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-29%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated November 13, 2024
1W -2.23 % 1M -0.75 % 3M -5.00 % 1Y 92.03 %

Key Metrics

Shape
  • Market Cap

    19.39B


  • Shares Outstanding

    1.13B


  • Share in Float

    1.13B


  • Dividende

    0


  • Earning Date

    29 Jan 2025


  • Price Target

    17.11


  • Average Volume

    6.66M


  • Beta

    0.868


  • Range

    8.64-19.31


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.tevapharm.com


  • Sector

    Healthcare


Fundamentals

Shape

6.15x

P/E Ratio

1.16x

P/S Ratio

3.04x

P/B Ratio

3.0

Debt/Equity

-5.9%

Net Margin

$-0.8

EPS

How TEVA compares to sector?

P/E Ratio

Relative Strength

Shape

TEVA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$17B

Shape293%

2025-Revenue

$2.79

Shape815%

2025-EPS

$4B

Shape2002%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

upgrade

Previous: Underweight

2024-02-12

Now: Overweight

Jefferies

upgrade

Previous: Positive

2024-01-23

Now: Buy

UBS

upgrade

Previous: Neutral

2023-11-27

Now: Buy

Evercore ISI

upgrade

Previous: Not converted

2023-05-18

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-8%

0.71
vs 0.77

Q1.23

arrow
arrow

-27%

0.4
vs 0.55

Q2.23

arrow
arrow

-18%

0.56
vs 0.68

Q3.23

arrow
arrow

+2%

0.6
vs 0.59

Q4.23

arrow
arrow

+41%

1
vs 0.71

Q1.24

arrow
arrow

+20%

0.48
vs 0.4

Q2.24

arrow
arrow

+9%

0.61
vs 0.56

Q3.24

arrow
arrow

+15%

0.69
vs 0.6

Q4.24

arrow
arrow

-31%

0.69
vs 1

Q1.25

arrow
arrow

+13%

0.54
vs 0.48

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-5%

3.9B  vs 4.1B

Q1.23

arrow
arrow

NA

3.7B  vs 3.7B

Q2.23

arrow
arrow

+2%

3.9B  vs 3.8B

Q3.23

arrow
arrow

+7%

3.9B  vs 3.6B

Q4.23

arrow
arrow

+15%

4.5B  vs 3.9B

Q1.24

arrow
arrow

+5%

3.8B  vs 3.7B

Q2.24

arrow
arrow

+7%

4.2B  vs 3.9B

Q3.24

arrow
arrow

+13%

4.3B  vs 3.9B

Q4.24

arrow
arrow

-8%

4.1B  vs 4.5B

Q1.25

arrow
arrow

+3%

3.9B  vs 3.8B

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-15%

-0.15
vs 0.01

Q1.23

arrow
arrow

-3%

-0.03
vs -0.15

Q2.23

arrow
arrow

-12%

-0.12
vs -0.03

Q3.23

arrow
arrow

+1%

0.01
vs -0.12

Q4.23

arrow
arrow

+6%

0.06
vs 0.01

Q1.24

arrow
arrow

-2%

-0.02
vs 0.06

Q2.24

arrow
arrow

-13%

-0.13
vs -0.02

Q3.24

arrow
arrow

-7%

-0.07
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

460

460
vs 493

-7%

Q4.22

arrow
arrow

459

459
vs 460

0%

Q1.23

arrow
arrow

470

470
vs 459

2%

Q2.23

arrow
arrow

464

464
vs 470

-1%

Q3.23

arrow
arrow

466

466
vs 464

0%

Q4.23

arrow
arrow

479

479
vs 466

3%

Q1.24

arrow
arrow

510

510
vs 479

6%

Q2.24

arrow
arrow

557

557
vs 510

9%

Earnings Growth

Latest News